Epstein Secrets

izer-s-covid-vaccine-trial-plan-may-beat- rivals-to-early-look?smd=premium> (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first look

fore reaching the final goal of 164." Modema won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro

n people." Pfizer's COVID Vaccine Trial On Track To Beat Rivals. Bloomberg (9/22, Langreth, 4.73M) reports, "The Covid-19 vaccine trial designed by Pfizer Inc. and its German partner BioNTech SE may allow them to find whether their shot works before their fastest-moving rivals." The firms "plan a first loo

re reaching the final goal of 164." Moderna won't "dive in until 53 cases have occurred; its ultimate goal is to make a judgment at 151 diagnoses." AstraZeneca will "take its first look at 75 cases, and not again until the trial is complete with 150." Federal Advisory Committee Postpones Vote On Vaccine Ro